BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 17349559)

  • 1. Complications of sclerotherapy.
    Munavalli GS; Weiss RA
    Semin Cutan Med Surg; 2007 Mar; 26(1):22-8. PubMed ID: 17349559
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sclerotherapy of varicose veins with polidocanol based on the guidelines of the German Society of Phlebology.
    Rabe E; Pannier F
    Dermatol Surg; 2010 Jun; 36 Suppl 2():968-75. PubMed ID: 20590702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sclerotherapy in tumescent anesthesia of reticular veins and telangiectasias.
    Ramelet AA
    Dermatol Surg; 2012 May; 38(5):748-51. PubMed ID: 22268802
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sclerotherapy for varicose and telangiectatic veins.
    Green D
    Am Fam Physician; 1992 Sep; 46(3):827-37. PubMed ID: 1514476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Visual disturbance following sclerotherapy for varicose veins, reticular veins and telangiectasias: a systematic literature review.
    Willenberg T; Smith PC; Shepherd A; Davies AH
    Phlebology; 2013 Apr; 28(3):123-31. PubMed ID: 23761921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cutaneous hyperpigmentation following venous sclerotherapy treated with deferoxamine mesylate.
    Lopez L; Dilley RB; Henriquez JA
    Dermatol Surg; 2001 Sep; 27(9):795-8. PubMed ID: 11553167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reducing hyperpigmentation after sclerotherapy: A randomized clinical trial.
    Gonzalez Ochoa AJ; Carrillo J; Manríquez D; Manrique F; Vazquez AN
    J Vasc Surg Venous Lymphat Disord; 2021 Jan; 9(1):154-162. PubMed ID: 32739509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ambulatory phlebectomy compared to sclerotherapy for varicose and telangiectatic veins: indications and complications.
    Weiss RA; Weiss MA
    Adv Dermatol; 1996; 11():3-16; discussion 17. PubMed ID: 8718471
    [No Abstract]   [Full Text] [Related]  

  • 9. [Local drugs in treating and decreasing the incidence of adverse reactions after sclerotherapy of telangiectasia].
    Bogachev VI; Boldin BV; Turkin PI; Lobanov VN
    Angiol Sosud Khir; 2019; 25(4):102-107. PubMed ID: 31855206
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cutaneous necrosis, telangiectatic matting, and hyperpigmentation following sclerotherapy. Etiology, prevention, and treatment.
    Goldman MP; Sadick NS; Weiss RA
    Dermatol Surg; 1995 Jan; 21(1):19-29; quiz 31-2. PubMed ID: 7600016
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Standard guidelines for care: sclerotherapy in dermatology.
    Khunger N; Sacchidanand S
    Indian J Dermatol Venereol Leprol; 2011; 77(2):222-31. PubMed ID: 21393966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subcutaneous injection of liquid and foamed polidocanol: extravasation is not responsible for skin necrosis during reticular and spider vein sclerotherapy.
    Schuller-Petrović S; Pavlović MD; Neuhold N; Brunner F; Wölkart G
    J Eur Acad Dermatol Venereol; 2011 Aug; 25(8):983-6. PubMed ID: 21740464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment of varicose veins and telangiectasias].
    Noël B
    Rev Med Suisse; 2007 May; 3(109):1124-9. PubMed ID: 17552271
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Telangiectasis after varicose vein exeresis].
    Schultz-Ehrenburg U; Matthes U
    Hautarzt; 1992 Jan; 43(1):51. PubMed ID: 1612910
    [No Abstract]   [Full Text] [Related]  

  • 15. Safety Concerns for Sclerotherapy of Telangiectases, Reticular and Varicose Veins.
    Yiannakopoulou E
    Pharmacology; 2016; 98(1-2):62-9. PubMed ID: 27104778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of reticular veins and telangiectases.
    Smith PC
    Phlebology; 2015 Nov; 30(2 Suppl):46-52. PubMed ID: 26556703
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sclerotherapy treatment of telangiectasias and varicose veins.
    Zimmet SE
    Tech Vasc Interv Radiol; 2003 Sep; 6(3):116-20. PubMed ID: 14614695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Small vessel sclerotherapy: an overview.
    Duffy DM
    Adv Dermatol; 1988; 3():221-42. PubMed ID: 3152820
    [No Abstract]   [Full Text] [Related]  

  • 19. [Surgical treatment of telangiectasis].
    Miyake H; Langer B; Albers MT; Bouabci AS; Telles JD
    Rev Hosp Clin Fac Med Sao Paulo; 1993; 48(5):209-13. PubMed ID: 8165405
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The treatment of microvarices, varicosities and telangiectasis in 1992].
    Guex JJ
    Phlebologie; 1992; 45(4):401-4; discussion 405-7. PubMed ID: 1302315
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.